Delivery apps are allowing Chinese citizens to get their hands on the popular weight-loss and diabetes drugs at the touch of ...

AstraZeneca will buy longtime partner FibroGen's China unit for about $160 million to gain rights to its anemia drug in the ...

US companies eagerly offshored their supply chains to drive down costs and boost profits. But today, the world economy is a ...

A quieter yet equally significant shift is under way in biotech. China has long been known for churning out generic drugs, supplying raw ingredients and managing clinical trials for the ...

Chinese money brokers are teaming up with Mexican cartels, greasing the wheels of the fentanyl trade, U.S. officials say.

President Donald Trump’s 10% tariff rule on imports coming from China could negatively impact and delay several pharmaceutical drugs that many Americans rely on to treat cardiovascular ...

The company, now based in North Beach, has lost more than $2 billion over 29 years. Its only approved drug, called roxadustat ...

AstraZeneca is paying $160 million for FibroGen’s China business, giving the U.K.-based Big Pharma the regional rights to ...

Between 2018 and 2024, China has launched 188 domestically developed innovative drugs – nearly double the number from the ...

China’s share of the global drug development pipeline grew from 3% in 2013 to 28% in 2023, positioning China as the second-largest region for clinical trials after the United States. Additionally, the ...

Chinese Commerce Minister Wang Wentao has expressed strong dissatisfaction with U.S. tariffs on Chinese goods in a letter ...

organising prostitution and drug trafficking - state broadcaster CCTV reported on Wednesday. According to CCTV, prosecutors in Wenzhou in China's eastern Zhejiang province alleged the Ming family ...